US Patent 7776920 Mandelic hydrazides
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+414 characters)
Article
Patent abstract
Novel mandelic hydrazides of the formula (I), in which R1-R11 have the meanings indicated in claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Florian Lang0
Markus Klein0
Norbert Beier0
Rolf Gericke0
Werner Mederski0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07776920 Mandelic hydrazides US Patent 7776920 Mandelic hydrazides
Infobox
Patent Number
077769200
Patent Number
77769200
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
077769200
Date of Patent
August 17, 2010
0Patent Application Number
122792270
Date Filed
January 18, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07776920 Mandelic hydrazides
Infobox
Is a
Patent jurisdiction
Patent number
07776920
Date of patent
August 17, 2010
Patent application number
12279227
Date Filed
January 18, 2007
Patent primary examiner
Find more entities like US Patent 7776920 Mandelic hydrazides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.